Get informed when a big investor buys or sells
+ Follow-108.56%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Novo Integrated Sciences (NVOS) currently reports a ROE of -108.56%. That is below the Industrials sector average of 35.28%. Use the charts on this page to explore Novo Integrated Sciences's ROE history and peer comparisons.
Novo Integrated Sciences's ROE of -108.56% is lower than the Industrials sector average of 35.28%. That is roughly 407.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Novo Integrated Sciences's current -108.56% should be judged against Industrials norms (sector average: 35.28%) and against NVOS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -108.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 35.28%. From there, open related valuation or income-statement pages for Novo Integrated Sciences, and consider following NVOS for alerts when major investors trade the stock.
Novo Integrated Sciences is classified in the Industrials sector. On ROE, it currently shows -108.56% versus a sector average near 35.28%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing NVOS with unrelated industries.